Atlas Trials

Phase 1

65,473 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 1

RecordFirmDate
Safety Study of 90Y-hMN14 to Treat Pancreatic Cancer (NCT00041639)Gilead Sciences2000-01-01
Pseudodrynaria Coronana (Wall) Ching (NCT00155675)National Taiwan University Hospital2000-01-01
Cardiac Hormone Replacement With Brain Natriuretic Peptide (BNP) in Heart Failure (NCT00252187)Horng Chen2000-01-01
Pharmacodynamics, Preliminary Pharmacokinetics and Tolerability of BIBB 1464 (Tablet) in Hyperlipemic Healthy Male Subjects (NCT02229773)Boehringer Ingelheim2000-01-01
Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCC (NCT00234182)The University of Hong Kong2000-01-01
Low-Dose Total-Body Irradiation and Fludarabine Phosphate Followed by Unrelated Donor Stem Cell Transplant in Treating Patients With Fanconi Anemia (NCT00093743)Fred Hutchinson Cancer Center2000-01-01
Treatment of Psoriasis With Parathyroid Hormone (NCT00007306)National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)2000-01-01
Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer (NCT00005065)National Cancer Institute (NCI)2000-01-01
Combination Chemotherapy In Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00005068)Mayo Clinic2000-01-01
Combination Chemotherapy Plus Biological Therapy in Treating Patients With Stage II or Stage III Breast Cancer (NCT00022230)Roger Williams Medical Center2000-01-01
Effects of Acetylsalicylic Acid Compared With the Combination of Acetylsalicylic Acid + Modified-release Dipyridamole on Serum Thromboxane B2 Formation and Platelet Aggregation in Healthy Volunteers (NCT02268773)Boehringer Ingelheim2000-01-01
Pharmacokinetics, Safety and Efficacy of BIIL 284 BS in Patients With Rheumatoid Arthritis (RA) (NCT02247375)Boehringer Ingelheim2000-01-01
Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs) (NCT00058591)Baylor College of Medicine2000-01-01
Samarium Sm 153 Lexidronam Pentasodium and High-Dose Melphalan in Treating Patients With Multiple Myeloma Undergoing Stem Cell Transplant (NCT00602706)Mayo Clinic2000-01-01
Total Lymphoid Irradiation (TLI) to Prevent Focal Segmental Glomerulosclerosis (FSGS)Recurrence in the Renal Graft (NCT00353535)University of Sao Paulo2000-01-01
First Administration to Man Of Org 25435 a New Intravenous Anesthetic (NCT01062867)University of Plymouth2000-01-01
B181: Stimulation of Thermogenesis by Bio-Active Food Ingredients (NCT00302289)University of Copenhagen2000-01-01
Photodynamic Therapy in Treating Patients With Basal Cell Skin Cancer (NCT00017485)Roswell Park Cancer Institute2000-01-01
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00004913)Northwestern University2000-01-01
Cardiac Operation Under Totally Endoscope and Cardiopulmonary Bypass (CPB) (NCT00921596)Xijing Hospital2000-01-01
Study of Vaccination With Autologous Acute Myeloblastic Leukemia Cells in Patients With Advanced Myelodysplasia or Acute Myelogenous Leukemia (NCT00136422)Dana-Farber Cancer Institute2000-01-01
Endoscopic Placement of Metal Stent in Patients With Cancer-Related Bowel Obstruction (NCT00004911)Northwestern University2000-01-01
A Trial in Healthy Volunteers, to Evaluate the Tolerability and Cardiac Safety of Prucalopride (NCT00488215)Movetis2000-01-01
Endoscopic Placement of Metal Stents in Treating Patients With Cancer- Related Duodenal Obstruction (NCT00004910)Northwestern University2000-01-01
Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy (NCT00005634)Memorial Sloan Kettering Cancer Center2000-01-01
PEG Interferon Alpha 2B and Low-Dose Ara-C in Early Chronic Phase CML (NCT00303290)M.D. Anderson Cancer Center2000-01-01
1-Octanol to Treat Essential Tremor (NCT00001986)National Institute of Neurological Disorders and Stroke (NINDS)2000-01-01
Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fasting Conditions (NCT01380483)Par Pharmaceutical, Inc.2000-01-01
Study Using Intensity-modulated Radiation Therapy in Patients With Nasopharynx Cancer to Permit Sparing of Contralateral Parotid Gland Function (NCT00123864)Alberta Health services2000-01-01
Effect of Salicylate on Glucose Metabolism in Insulin Resistance States (NCT00258128)Joslin Diabetes Center2000-01-01
Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Adenocarcinoma of the Breast (NCT02204046)Boehringer Ingelheim2000-01-01
Gene Therapy Plus Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer (NCT00004225)Eastern Cooperative Oncology Group2000-01-01
Once-Daily Drug Regimen for HIV-Infected Patients (NCT00001968)National Institute of Allergy and Infectious Diseases (NIAID)2000-01-01
Oxaliplatin and Fluorouracil Plus Radiation Therapy in Treating Patients With Primary Esophageal or Stomach Cancer (NCT00004257)Albany Medical College2000-01-01
Magnetic Resonance Imaging to Detect Blood Vessel Inflammation in Patients Undergoing Peripheral Balloon Angioplasty (NCT00004549)National Heart, Lung, and Blood Institute (NHLBI)2000-01-01
Paclitaxel Combined With Fluorouracil-Uracil and Leucovorin in Treating Patients With Solid Tumors (NCT00009828)University of Pittsburgh1999-12-01
Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma (NCT00005815)Memorial Sloan Kettering Cancer Center1999-12-01
Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome (NCT00004918)National Cancer Institute (NCI)1999-12-01
Phase I and II Study Of Stereotactic Body Radiotherapy in Medically Unresectable Patients With Stage 1 NSCLC (NCT00246181)Jill Deluca1999-12-01
Gene Therapy in Treating Patients With Recurrent or Progressive Brain Tumors (NCT00004080)National Cancer Institute (NCI)1999-12-01
MS 209 Plus Docetaxel in Treating Patients With Advanced Solid Tumors (NCT00004886)European Organisation for Research and Treatment of Cancer - EORTC1999-12-01
Combination Chemotherapy in Treating Patients With Advanced Solid Tumors (NCT00009815)University of Pittsburgh1999-12-01
FIM-BR - First-in-Man Study (Brazil Part) With Sirolimus-Coated BX VELOCITY Stent (NCT00233792)Cordis US Corp.1999-12-01
Vascular Effects of Endothelium-Derived Versus Hemoglobin-Transported Nitric Oxide in Healthy Subjects (NCT00001963)National Heart, Lung, and Blood Institute (NHLBI)1999-12-01
EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer (NCT00004258)Indiana University1999-12-01
Cytarabine and UCN-01 in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia or Myelodysplastic Syndrome (NCT00004263)M.D. Anderson Cancer Center1999-12-01
EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma (NCT00004261)University Health Network, Toronto1999-12-01
Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer (NCT00005827)UNC Lineberger Comprehensive Cancer Center1999-12-01
Biodistribution Study With 186 Re-labelled Humanised Monoclonal Antibody BIWA 4 in Patients With Non-small Cell Lung Cancer (NCT02204059)Boehringer Ingelheim1999-12-01
Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer (NCT00006042)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins1999-12-01
Comparison of Magnetic Resonance Angiography and Standard Angiography in Diagnosing Atherosclerosis (NCT00001946)National Institutes of Health Clinical Center (CC)1999-12-01
Study of Treatment and Metabolism in Patients With Urea Cycle Disorders (NCT00004307)National Center for Research Resources (NCRR)1999-12-01
Paclitaxel and Hyperthermic Perfusion in Treating Patients With Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery (NCT00020007)National Cancer Institute (NCI)1999-12-01
506U78 in Treating Patients With Hematologic Cancer and Kidney or Liver Impairment (NCT00004239)Alliance for Clinical Trials in Oncology1999-12-01
Vinorelbine and XR9576 to Treat Cancer (NCT00001944)National Cancer Institute (NCI)1999-12-01
Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma (NCT00005637)Memorial Sloan Kettering Cancer Center1999-12-01
Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Solid Tumors (NCT00005061)European Organisation for Research and Treatment of Cancer - EORTC1999-12-01
Pharmacokinetic Study of Porfiromycin in Head and Neck Cancer and Other Cancer Patients With Solid Tumors (NCT02209701)Boehringer Ingelheim1999-12-01
Anti-Tac for Treatment of Leukemia (NCT00001941)National Cancer Institute (NCI)1999-12-01
Bone Marrow Transplantation in Treating Children With Sickle Cell Disease (NCT00004485)Fred Hutchinson Cancer Center1999-12-01
Cordis Bilateral AAA Device Compared to Open Surgical Repair of Abdominal Aortic Aneurysms (ARIBA) (NCT00235118)Cordis US Corp.1999-12-01
Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy (NCT00004919)National Cancer Institute (NCI)1999-12-01
Stem Cell Transplant for Juvenile Myelomonocytic Leukemia (JMML) (NCT00167219)Masonic Cancer Center, University of Minnesota1999-11-18
Comparison of Two Formulations of Biphasic Insulin Aspart 70 (NCT01523041)Novo Nordisk A/S1999-11-03
Vasoreactivity in Carriers of Genetic Polymorphisms (NCT00160888)Heidelberg University1999-11-01
Safety, Tolerability and Pharmacodynamics After Oral Administration of BIIF 1149 BS in Healthy Male Volunteers (NCT02209714)Boehringer Ingelheim1999-11-01
MRI Sarcoma Non Invasive Thermometry (NCT00093509)Mark Dewhirst1999-11-01
Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions (NCT01380496)Par Pharmaceutical, Inc.1999-11-01
Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer (NCT00003379)Gynecologic Oncology Group1999-11-01
Assessment of Safety, Pharmacokinetics and the Effect of BIBR 1048 MS on Coagulation Parameters in Healthy Volunteer Subjects (NCT02170740)Boehringer Ingelheim1999-11-01
Irinotecan and Cytarabine in Treating Patients With Refractory or Recurrent Acute Myeloid Leukemia or Chronic Myelogenous Leukemia (NCT00053144)Roswell Park Cancer Institute1999-11-01
Brachytherapy in Treating Patients With Recurrent Prostate Cancer (NCT00005939)Center for Molecular Medicine1999-11-01
Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme (NCT00004262)National Cancer Institute (NCI)1999-11-01
Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic Cancer (NCT00006225)Northwestern University1999-11-01
Study to Evaluate the Safety and Immunogenicity of MEDI-517P in Healthy Adult Female Volunteers Who Are HPV-16 or HPV-18 DNA Positive (NCT00263744)MedImmune LLC1999-11-01
Safety, Tolerability and Pharmacokinetics of Increasing Repeated Doses of BIIF 1149 BS in Healthy Male Volunteers (NCT02203487)Boehringer Ingelheim1999-11-01
Phase I Study of Retrovirally Mediated Transfer of the Human Glucocerebrosidase Gene Into Peripheral Blood Stem Cells for Autologous Transplantation in Patients With Type I Gaucher Disease (NCT00004294)National Center for Research Resources (NCRR)1999-11-01
Phosphorus-32 Plus Radiation Therapy and Chemotherapy in Treating Patients With Stage II or Stage III Non-small Cell Lung Cancer (NCT00006212)Center for Molecular Medicine1999-11-01
PS-341 in Treating Patients With Advanced Cancer (NCT00006362)Mayo Clinic1999-11-01
Monoclonal Antibody Therapy in Treating Patients With Recurrent Non-Hodgkin's Lymphoma (NCT00004101)National Cancer Institute (NCI)1999-11-01
Neuroblastoma Vaccine for Treatment of High-Risk Neuroblastoma After Chemotherapy (NCT00048386)Malcolm Brenner1999-11-01
Pilot Study to Assess the Pharmacokinetics of Intravenous Nabi 5% Hepatitis B Immune Globulin (Boca HBVIg) Used in Combination With Lamivudine for Patients With Hepatitis B Virus (HBV) Associated Liver Disease Undergoing Liver Transplantation (NCT01421212)Biotest Pharmaceuticals Corporation1999-11-01
Single Increasing Dose Followed by Maintenance Dose Tolerance Study of BIIR 561 CL in Healthy Male Volunteers (NCT02222961)Boehringer Ingelheim1999-11-01
Chemotherapy Plus Trastuzumab in Treating Patients With Breast Cancer (NCT00014430)Dartmouth-Hitchcock Medical Center1999-11-01
Vaccine Therapy in Treating Patients With Recurrent or Persistent Cervical Cancer (NCT00003977)Steward St. Elizabeth's Medical Center of Boston, Inc.1999-11-01
Effects on the Airway Lumen of Talsaclidine in Combination With Propranolol in Comparison to the Effects of the Monosubstances in Healthy Elderly Male Volunteers (NCT02264093)Boehringer Ingelheim1999-11-01
Relative Bioavailability, Pharmacokinetics, Safety and Tolerability of BIIL 284 BS in Healthy Volunteers (NCT02265653)Boehringer Ingelheim1999-11-01
Guanfacine for the Treatment of Post Traumatic Stress Disorder (PTSD) (NCT00018603)US Department of Veterans Affairs1999-11-01
Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix (NCT00003377)Gynecologic Oncology Group1999-11-01
Clinical Study of Aneurysm Exclusion (NCT00549380)Arizona Heart Institute1999-10-01
Bioavailability of Lacidipine and Telmisartan Fixed Dose Combination Tablets Relative to Separate Tablets in Healthy Subjects (NCT02209649)Boehringer Ingelheim1999-10-01
17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Advanced Epithelial Cancer, Malignant Lymphoma, or Sarcoma (NCT00004241)National Cancer Institute (NCI)1999-10-01
Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Esophageal Cancer (NCT00005638)Memorial Sloan Kettering Cancer Center1999-10-01
Treatment of Advanced AIDS Patients With Dextrin Sulfate (NCT00004987)Steinhart Medical Associates1999-10-01
Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation in Treating Patients With Advanced Breast Cancer (NCT00004174)Northwestern University1999-10-01
Safety and Tolerability of COMBIVENT® HFA as Compared to COMBIVENT® CFC and Placebo HFA in Healthy Male and Female Subjects (NCT02173678)Boehringer Ingelheim1999-10-01
Metabolism and Pharmacokinetics of [14C]-BIIL 284 BS in Healthy Volunteers (NCT02266550)Boehringer Ingelheim1999-10-01
Augmerosen Plus Fludarabine and Cytarabine in Treating Patients With Refractory or Relapsed Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia (NCT00004862)National Cancer Institute (NCI)1999-10-01
A Trial Investigating the Relationship Between Pharmacodynamic and Interstitial Concentration for Insulin Detemir and Human Insulin (NCT02162407)Novo Nordisk A/S1999-10-01
Combination Chemotherapy in Treating Patients With Metastatic or Unresectable Solid Tumors (NCT00004242)National Cancer Institute (NCI)1999-10-01
← Previous Next →

Track Phase 1 automatically

Every clearance here is in the API, with alerts when new ones post.